Aaron Fletcher Ph.D Overview
- Firm
- Bios Partners
- Primary Position
-
Co-Founder, Mana...
- Primary Industry
-
Healthcare
- Active Board Seats
-
4
- Med. Deal Size
-
- Med. Valuation
-
Aaron Fletcher Ph.D General Information
Biography
Dr. Aaron Fletcher is a Co-Founder and serves as Managing Partner & Managing Director at Bios Partners. He served as Board Member at Abilitech Medical. He is the Founder and serves as President & Chief Compliance Officer at Bios Research. He holds a PhD in Biochemistry from Colorado State University and serves as a professor at Dallas Baptist University where he teaches Biochemistry, Bioethics, and Cell Biology. Dr. Fletcher has worked as an independent consultant for the biotech/healthcare equity industry for over 8 years. He serves as a Board Chairman at TFF Pharmaceuticals.
Contact Information
Address
- 1751 River Run
- Suite 400
- Fort Worth, TX 76107
- United States
Aaron Fletcher Ph.D Positions (2)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
Bios Partners | Investor | Co-Founder, Managing Partner & Managing Director | Fort Worth, TX | Venture Capital | |
Bios Research | Investor | Founder, President & Chief Compliance Officer | Fort Worth, TX | Hedge Fund |
Aaron Fletcher Ph.D Board Seats (4)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
Actuate Therapeutics | Drug Discovery | Publicly Held | Formerly VC-backed | Fort Worth, TX | |
Cognition Therapeutics | Drug Discovery | Publicly Held | Formerly VC-backed | New York, NY | |
Lung Therapeutics | Drug Discovery | Acquired/Merged (Operating Subsidiary) | Formerly VC-backed | Austin, TX | |
ONL Therapeutics | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Ann Arbor, MI |
Aaron Fletcher Ph.D Lead Partner on Deals (6)
Aaron Fletcher Ph.D has been the lead partner on 6 deals. Their latest deal was with Lung Therapeutics, a drug discovery company. The deal was made for on 31-Oct-2019.
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Lung Therapeutics | 31-Oct-2019 | Later Stage VC (Series C) | Completed | Drug Discovery | Austin, TX | |
Actuate Therapeutics | 30-Apr-2019 | Completed | Drug Discovery | Fort Worth, TX | ||
Abilitech Medical | 17-Mar-2017 | Completed | Therapeutic Devices | Eden Prairie, MN | ||
Lung Therapeutics | 01-Mar-2016 | Completed | Drug Discovery | Austin, TX | ||
Cognition Therapeutics | 01-Aug-2015 | Later Stage VC (Series B) | Completed | Drug Discovery | New York, NY | |
Lung Therapeutics | 10-Sep-2014 | Early Stage VC (Series A) | Completed | Drug Discovery | Austin, TX |
Aaron Fletcher Ph.D Network (133)
Board Members (89)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Donald Santel | Abilitech Medical | Self | Eden Prairie, MN | |
Cynthia Grosskreutz MD | ONL Therapeutics | ONL Therapeutics | Ann Arbor, MI | |
TFF Pharmaceuticals | Self | Fort Worth, TX | ||
TFF Pharmaceuticals | Self | Fort Worth, TX | ||
TFF Pharmaceuticals | Self | Fort Worth, TX |
Portfolio Executives (41)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Andrew Mazar Ph.D | Lung Therapeutics | Co-Founder | 31-Oct-2019 | Austin, TX |
Steven Idell Ph.D | Lung Therapeutics | Co-Founder & Chief Scientific Officer | 31-Oct-2019 | Austin, TX |
Lung Therapeutics | Vice President, CMC - Inhalation Products | 31-Oct-2019 | Austin, TX | |
Lung Therapeutics | Vice President, Operations | 31-Oct-2019 | Austin, TX | |
Lung Therapeutics | Chief Financial Officer, Secretary & Treasurer | 31-Oct-2019 | Austin, TX |
Fund Team Members (3)
Name | Investor | Fund | Fund Location |
---|---|---|---|
Stella Robertson Ph.D | Bios Partners | Bios Fund II | Fort Worth, TX |
Stella Robertson Ph.D | Bios Partners | Bios Fund I | Fort Worth, TX |
Bios Partners | Fort Worth, TX |
Aaron Fletcher Ph.D Affiliated Funds (2)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
Bios Fund II | Bios Partners | Venture - General | Closed | 2018 | ||||
Bios Fund I | Bios Partners | Venture - General | Fully Invested | 2017 |
Aaron Fletcher Ph.D FAQs
-
Who is Aaron Fletcher Ph.D?
Dr. Aaron Fletcher is a Co-Founder and serves as Managing Partner & Managing Director at Bios Partners.
-
How much does Aaron Fletcher Ph.D typically invest?
Aaron Fletcher Ph.D's median deal size is
. -
What is Aaron Fletcher Ph.D’s main position?
Aaron Fletcher Ph.D’s primary position is Co-Founder, Managing Partner & Managing Director.
-
What are the contact details for Aaron Fletcher Ph.D?
Aaron Fletcher Ph.D’s email address is af
and his phone number is +1 (817) . -
How many active board seats does Aaron Fletcher Ph.D hold?
Aaron Fletcher Ph.D holds 4 board seats including Actuate Therapeutics, Cognition Therapeutics, Lung Therapeutics, and ONL Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »